[Form 4] Paramount Global Insider Trading Activity

Rhea-AI Filing Summary

Paramount Global (PARAA) filed a Form 4 disclosing a routine equity grant to director Charles E. Ryan. On 07/02/2025 Mr. Ryan received 16,340 Restricted Share Units (RSUs) under the company’s outside-director equity plan at a grant price of $0.00. The RSUs will vest on the earlier of the 2026 Annual Meeting or 02 July 2026, at which point an equal number of Class B shares will be delivered unless deferred. Following the transaction, Mr. Ryan’s beneficial ownership increased by the same 16,340 shares and remains direct. No shares were sold or transferred, and there are no derivative exercises or cash proceeds involved. The filing does not alter Paramount Global’s capital structure in any material way and represents customary director compensation intended to align board incentives with shareholder interests.

Insights

Equity Compensation Analyst

TL;DR: Routine director RSU grant; neutral impact.

This Form 4 details a standard annual equity award of 16,340 RSUs to outside director Charles E. Ryan. The grant, made at no cost, vests over roughly one year, matching peer governance practices and fostering alignment with shareholders. With Paramount Global’s ~650 million shares outstanding, the dilution effect is immaterial (<0.003%). The filing signals no insider purchase or sale and therefore provides limited insight into management’s market view. Overall, it is an administrative disclosure with negligible financial impact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ryan Charles E

(Last) (First) (Middle)

1515 BROADWAY

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Paramount Global [ PARAA,PARA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units(1)	(2)	07/02/2025		A		16,340		(2)	(2)	Class B common stock	16,340	$0.0000(1)	16,340	D

Explanation of Responses:

1. Granted under the Issuer's equity plan for outside directors for no consideration.

2. These Restricted Share Units will generally vest on the earlier of (i) the date of the Issuer's 2026 Annual Meeting of Stockholders and (ii) July 2, 2026, and a corresponding number of Class B shares will be delivered on the vesting date, unless the director has elected to defer receipt.

	/s/ Caryn K. Groce, Attorney-in-Fact for Charles E. Ryan	07/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Paramount Global (PARAA) disclose in the July 2025 Form 4?

The company granted 16,340 RSUs to director Charles E. Ryan on 07/02/2025.

When do the 16,340 RSUs granted to Charles E. Ryan vest?

They vest on the earlier of the 2026 Annual Meeting or July 2, 2026.

Did the director pay anything for the RSUs?

No. The RSUs were granted for no consideration under the outside-director equity plan.

How does this Form 4 affect Paramount Global’s share count?

The grant adds a de minimis 16,340 potential Class B shares, an immaterial dilution of under 0.003%.

Is the transaction classified as a purchase or sale of shares?

Neither. It’s an equity grant; no shares were bought or sold.